← Intelligence Vault
researchSystematic Reviewprofessional1 min read
Pathogenesis and treatment of rosacea: an updated review
Authors · Two AM, Wu W, Gallo RL et al.
Journal · Journal of the American Academy of Dermatology · April 2015
What this means for you
The plain-language read
Rosacea is a multifactorial inflammatory skin disease involving neurovascular dysregulation, innate immune hyperactivity (cathelicidin), Demodex mite overgrowth, and barrier dysfunction. Standard-of-care includes ivermectin 1% cream (for papulopustular subtype), brimonidine 0. 33% gel (for erythematotelangiectatic), oral doxycycline 40mg, and topical metronidazole.
Key findings
- Multifactorial pathogenesis requires multi-pronged therapy
- Subantimicrobial doxycycline (40mg) achieves anti-inflammatory benefit without resistance
- Trigger avoidance (heat, alcohol, sun, spice) is non-negotiable
- Barrier support is foundational — gentle cleansing, ceramides, daily SPF
Practical note
Build a rosacea protocol on barrier support first, then layer subtype-appropriate prescription therapy. Skip exfoliating acids and strong retinoids during flares.
Translate to action
What this means for your routine
ivermectinAM/PM routine1%
If you're targeting rosacea, this research supports adding ivermectin to your AM/PM routine. Effective concentration range: 1% based on this study.
metronidazoleAM/PM routine1%
If you're targeting rosacea, this research supports adding metronidazole to your AM/PM routine. Effective concentration range: 1% based on this study.
Translated from this study's findings, not a personal prescription. Pair with your existing protocol and your practitioner's guidance.
Technical Summary, For Professional Reference
Clinical context
Rosacea involves neurovascular dysregulation, cathelicidin/KLK5 overexpression, Demodex folliculorum density, and impaired barrier. Subtype-specific therapy: ivermectin 1% for papulopustular, brimonidine 0.33% gel for ETR, oral subantimicrobial doxycycline (40mg MR), topical metronidazole and azelaic acid as foundations.
Ingredients discussed
Full abstract→
Rosacea is a multifactorial inflammatory skin disease involving neurovascular dysregulation, innate immune hyperactivity (cathelicidin), Demodex mite overgrowth, and barrier dysfunction. Standard-of-care includes ivermectin 1% cream (for papulopustular subtype), brimonidine 0.33% gel (for erythematotelangiectatic), oral doxycycline 40mg, and topical metronidazole. Lifestyle triggers (heat, alcohol, spicy food, sun) must be co-managed.
Original source →Related research
ingredientsRCT
Changes in ultraviolet a radiation-induced thymidine dimers and erythema after oral nicotinamide or polypodium leucotomos extract in healthy volunteers: a randomized intraindividual trial.
Photochem Photobiol Sci · May 2026
Nicotinamide (NAM) and Polypodium leucotomos extract (PL) have demonstrated photoprotective effects, but their role in preventing UVA-induced DNA damage in humans remains unclear. To evaluate the effects of oral NAM and PL on UVA-induced erythema and thymidine dimer (TT-dimer) formation. In this intraindividual trial, 50 healthy volunteers (phototypes I-III) were randomized (1:1) to receive either NAM (2000 mg daily) or PL (Heliocare Advanced: 480 mg daily) for 30 days.
niacinamidepharosacea
Read →ingredientsRCT
Hyaluronic acid-based skin booster with glutathione combined with 1064-nm Nd:YAG laser and oral tranexamic acid for melasma: A prospective comparative study.
Medicine (Baltimore) · Oct 2026
Melasma is a chronic, acquired facial hyperpigmentation disorder with multifactorial pathogenesis and frequent relapse. Low-fluence 1064-nm Q-switched neodymium-doped yttrium aluminum garnet (Nd:YAG) (LQSNY) laser with oral tranexamic acid (TA) is widely used, but responses are often incomplete and short-lived. glutathione (GSH), an antioxidant that inhibits melanogenesis, may improve outcomes when delivered intradermally with a hyaluronic acid (HA) carrier.
hyaluronic_acidtranexamic_acidglutathione
Read →protocolsRCT
Device-Free Auricular Acupressure for Rosacea: A Randomized Clinical Trial.
JAMA Dermatol · Oct 2026
To evaluate the clinical efficacy of device-free auricular acupressure for rosacea and verify its neuroimmunomodulatory effects using serum biomarkers and immediate vascular imaging in a sham-controlled trial. DESIGN, SETTING, AND PARTICIPANTS: This single-center, randomized, sham-controlled, assessor-masked trial was conducted in the Dermatology Outpatient Department of the Second Affiliated Hospital of Xi'an Jiaotong University from October 2025 to May 2026 and included 204 patients with rosacea who were receiving standard first-line treatment. Participants were assigned in a 1:1 ratio using block randomization.
peptidesagingrosacea
Read →